• Je něco špatně v tomto záznamu ?

Sinonasal Undifferentiated Carcinoma (SNUC): From an Entity to Morphologic Pattern and Back Again-A Historical Perspective

A. Agaimy, A. Franchi, VJ. Lund, A. Skálová, JA. Bishop, A. Triantafyllou, S. Andreasen, DR. Gnepp, H. Hellquist, LDR. Thompson, A. Rinaldo, A. Ferlito,

. 2020 ; 27 (2) : 51-60. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028416

Since the first description of sinonasal undifferentiated carcinoma (SNUC) as a distinctive highly aggressive sinonasal neoplasm with probable origin from the sinonasal mucosa (Schneiderian epithelium), SNUC has been the subject of ongoing study and controversy. In particular, the SNUC category gradually became a "wastebasket" for any undifferentiated or unclassifiable sinonasal malignancy of definite or probable epithelial origin. However, with the availability of more specific and sensitive immunohistochemical antibodies and increasing implementation of novel genetic tools, the historical SNUC category became the subject of progressive subdivision leading to recognition of specific genetically defined, reproducible subtypes. These recently recognized entities are characterized by distinctive genetic aberrations including NUTM1-rearranged carcinoma (NUT carcinoma) and carcinomas associated with inactivation of different members of the SWI/SNF chromatin-remodeling gene complex such as SMARCB1-deficient and less frequently SMARCA4-deficient carcinoma. The ring became almost closed, with recent studies highlighting frequent oncogenic IDH2 mutations in the vast majority of histologically defined SNUCs, with a frequency of 82%. A review of these cases suggests the possibility that "true SNUC" probably represents a distinctive neoplastic disease entity, morphologically, phenotypically, and genetically. This review addresses this topic from a historical perspective, with a focus on recently recognized genetically defined subsets within the SNUC spectrum.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028416
003      
CZ-PrNML
005      
20210114153813.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/PAP.0000000000000258 $2 doi
035    __
$a (PubMed)31876536
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Agaimy, Abbas $u Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital, Erlangen, Germany.
245    10
$a Sinonasal Undifferentiated Carcinoma (SNUC): From an Entity to Morphologic Pattern and Back Again-A Historical Perspective / $c A. Agaimy, A. Franchi, VJ. Lund, A. Skálová, JA. Bishop, A. Triantafyllou, S. Andreasen, DR. Gnepp, H. Hellquist, LDR. Thompson, A. Rinaldo, A. Ferlito,
520    9_
$a Since the first description of sinonasal undifferentiated carcinoma (SNUC) as a distinctive highly aggressive sinonasal neoplasm with probable origin from the sinonasal mucosa (Schneiderian epithelium), SNUC has been the subject of ongoing study and controversy. In particular, the SNUC category gradually became a "wastebasket" for any undifferentiated or unclassifiable sinonasal malignancy of definite or probable epithelial origin. However, with the availability of more specific and sensitive immunohistochemical antibodies and increasing implementation of novel genetic tools, the historical SNUC category became the subject of progressive subdivision leading to recognition of specific genetically defined, reproducible subtypes. These recently recognized entities are characterized by distinctive genetic aberrations including NUTM1-rearranged carcinoma (NUT carcinoma) and carcinomas associated with inactivation of different members of the SWI/SNF chromatin-remodeling gene complex such as SMARCB1-deficient and less frequently SMARCA4-deficient carcinoma. The ring became almost closed, with recent studies highlighting frequent oncogenic IDH2 mutations in the vast majority of histologically defined SNUCs, with a frequency of 82%. A review of these cases suggests the possibility that "true SNUC" probably represents a distinctive neoplastic disease entity, morphologically, phenotypically, and genetically. This review addresses this topic from a historical perspective, with a focus on recently recognized genetically defined subsets within the SNUC spectrum.
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a karcinom $x diagnóza $x epidemiologie $x genetika $7 D002277
650    _2
$a DNA-helikasy $x genetika $7 D004265
650    _2
$a lidé $7 D006801
650    _2
$a nádory sinu maxillaris $x diagnóza $x epidemiologie $x genetika $7 D008444
650    _2
$a jaderné proteiny $x genetika $7 D009687
650    _2
$a gen SMARCB1 $x genetika $7 D000071796
650    _2
$a transkripční faktory $x genetika $7 D014157
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Franchi, Alessandro $u Department of Translational Research, School of Medicine, University of Pisa, Pisa.
700    1_
$a Lund, Valerie J $u Royal National Throat, Nose and Ear Hospital, University College London Hospitals, London.
700    1_
$a Skálová, Alena $u Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic.
700    1_
$a Bishop, Justin A $u Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.
700    1_
$a Triantafyllou, Asterios $u Department of Pathology, Liverpool Clinical Laboratories, Royal Liverpool University Hospital. School of Dentistry, University of Liverpool, Liverpool, UK.
700    1_
$a Andreasen, Simon $u Departments of Pathology. Otolaryngology Head and Neck Surgery. Audiology, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Gnepp, Douglas R $u Alpert Medical School at Brown University, Providence, RI.
700    1_
$a Hellquist, Henrik $u Epigenetics and Human Disease Laboratory, Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.
700    1_
$a Thompson, Lester D R $u Department of Pathology, Southern California Permanente Medical Group, Woodland Hills, CA.
700    1_
$a Rinaldo, Alessandra $u University of Udine School of Medicine, Udine.
700    1_
$a Ferlito, Alfio $u International Head and Neck Scientific Group, Padua, Italy.
773    0_
$w MED00000158 $t Advances in anatomic pathology $x 1533-4031 $g Roč. 27, č. 2 (2020), s. 51-60
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31876536 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114153810 $b ABA008
999    __
$a ok $b bmc $g 1608751 $s 1119596
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 27 $c 2 $d 51-60 $e - $i 1533-4031 $m Advances in anatomic pathology $n Adv Anat Pathol $x MED00000158
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace